Do analysts prefer PETV or HYPR?

Hyperfine has a consensus price target of $2.03, indicating a potential upside of 127.95%. Given Hyperfine's stronger consensus rating and higher probable upside, analysts clearly believe Hyperfine is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Hyperfine 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has stronger earnings and valuation, PETV or HYPR?

PetVivo has higher earnings, but lower revenue than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PetVivo $1.05M 24.58 -$10.95M -$0.34 N/A Hyperfine $11.40M 8.30 -$35.57M -$0.38 N/A

Is PETV or HYPR more profitable?

Hyperfine has a net margin of -210.75% compared to PetVivo's net margin of -902.82%. Hyperfine's return on equity of -97.88% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets PetVivo -902.82% -4,813.07% -281.78% Hyperfine -210.75% -97.88% -61.81%

Does the media favor PETV or HYPR?

In the previous week, Hyperfine had 2 more articles in the media than PetVivo. MarketBeat recorded 5 mentions for Hyperfine and 3 mentions for PetVivo. Hyperfine's average media sentiment score of 0.65 beat PetVivo's score of 0.00 indicating that Hyperfine is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hyperfine 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate PETV or OM?

Outset Medical has a consensus price target of $10.00, indicating a potential upside of 139.52%. Given Outset Medical's stronger consensus rating and higher possible upside, analysts plainly believe Outset Medical is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Outset Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Is PETV or OM more profitable?

Outset Medical has a net margin of -63.06% compared to PetVivo's net margin of -902.82%. Outset Medical's return on equity of -61.67% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets PetVivo -902.82% -4,813.07% -281.78% Outset Medical -63.06% -61.67% -28.25%

Does the media prefer PETV or OM?

In the previous week, Outset Medical had 3 more articles in the media than PetVivo. MarketBeat recorded 6 mentions for Outset Medical and 3 mentions for PetVivo. Outset Medical's average media sentiment score of 0.54 beat PetVivo's score of 0.00 indicating that Outset Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Outset Medical 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate PETV or NRXS?

NeurAxis has a consensus price target of $13.00, suggesting a potential upside of 107.50%. Given NeurAxis' stronger consensus rating and higher possible upside, analysts clearly believe NeurAxis is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 NeurAxis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has stronger valuation and earnings, PETV or NRXS?

PetVivo has higher earnings, but lower revenue than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PetVivo $1.05M 24.58 -$10.95M -$0.34 N/A NeurAxis $5.32M 14.80 -$14.63M -$0.78 N/A

Is PETV or NRXS more profitable?

NeurAxis has a net margin of -492.76% compared to PetVivo's net margin of -902.82%. NeurAxis' return on equity of 0.00% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets PetVivo -902.82% -4,813.07% -281.78% NeurAxis -492.76% N/A -641.25%

Does the media favor PETV or NRXS?

In the previous week, PetVivo had 1 more articles in the media than NeurAxis. MarketBeat recorded 3 mentions for PetVivo and 2 mentions for NeurAxis. NeurAxis' average media sentiment score of 0.20 beat PetVivo's score of 0.00 indicating that NeurAxis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NeurAxis 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer LUNG or PETV?

Pulmonx presently has a consensus target price of $7.67, indicating a potential upside of 237.89%. Given Pulmonx's stronger consensus rating and higher possible upside, equities analysts plainly believe Pulmonx is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulmonx 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation & earnings, LUNG or PETV?

PetVivo has lower revenue, but higher earnings than Pulmonx. PetVivo is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pulmonx $87.44M 1.11 -$54M -$1.16 N/A PetVivo $1.05M 24.58 -$10.95M -$0.34 N/A

Is LUNG or PETV more profitable?

Pulmonx has a net margin of -55.03% compared to PetVivo's net margin of -902.82%. Pulmonx's return on equity of -96.66% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets Pulmonx -55.03% -96.66% -38.32% PetVivo -902.82% -4,813.07% -281.78%

Does the media refer more to LUNG or PETV?

In the previous week, Pulmonx and Pulmonx both had 3 articles in the media. Pulmonx's average media sentiment score of 1.11 beat PetVivo's score of 0.00 indicating that Pulmonx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulmonx 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer NNOX or PETV?

Nano-X Imaging currently has a consensus price target of $4.33, indicating a potential upside of 387.99%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, equities research analysts clearly believe Nano-X Imaging is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nano-X Imaging 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.50 PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is NNOX or PETV more profitable?

Nano-X Imaging has a net margin of -716.44% compared to PetVivo's net margin of -902.82%. Nano-X Imaging's return on equity of -70.96% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets Nano-X Imaging -716.44% -70.96% -62.26% PetVivo -902.82% -4,813.07% -281.78%

Does the media refer more to NNOX or PETV?

In the previous week, Nano-X Imaging had 3 more articles in the media than PetVivo. MarketBeat recorded 6 mentions for Nano-X Imaging and 3 mentions for PetVivo. Nano-X Imaging's average media sentiment score of 0.41 beat PetVivo's score of 0.00 indicating that Nano-X Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nano-X Imaging 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

PetVivo (PETV) Competitors

$0.68 0.00 (-0.72%)

As of 01:29 PM Eastern

Compare

PETV vs. HYPR, OM, NRXS, LUNG, and NNOX

Should you buy PetVivo stock or one of its competitors? PetVivo's main competitors and comparable companies include Hyperfine (HYPR), Outset Medical (OM), NeurAxis (NRXS), Pulmonx (LUNG), and Nano-X Imaging (NNOX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does PetVivo compare to Hyperfine?

PetVivo (NASDAQ:PETV) and Hyperfine (NASDAQ:HYPR) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

In the previous week, Hyperfine had 2 more articles in the media than PetVivo. MarketBeat recorded 5 mentions for Hyperfine and 3 mentions for PetVivo. Hyperfine's average media sentiment score of 0.65 beat PetVivo's score of 0.00 indicating that Hyperfine is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hyperfine	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hyperfine has a net margin of -210.75% compared to PetVivo's net margin of -902.82%. Hyperfine's return on equity of -97.88% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Hyperfine	-210.75%	-97.88%	-61.81%

Hyperfine has a consensus price target of $2.03, indicating a potential upside of 127.95%. Given Hyperfine's stronger consensus rating and higher probable upside, analysts clearly believe Hyperfine is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Hyperfine	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

24.5% of PetVivo shares are held by institutional investors. Comparatively, 15.0% of Hyperfine shares are held by institutional investors. 10.8% of PetVivo shares are held by insiders. Comparatively, 26.3% of Hyperfine shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

PetVivo has higher earnings, but lower revenue than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	24.58	-$10.95M	-$0.34	N/A
Hyperfine	$11.40M	8.30	-$35.57M	-$0.38	N/A

PetVivo has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market. Comparatively, Hyperfine has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market.

Summary

Hyperfine beats PetVivo on 11 of the 16 factors compared between the two stocks.

How does PetVivo compare to Outset Medical?

PetVivo (NASDAQ:PETV) and Outset Medical (NASDAQ:OM) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk and earnings.

Outset Medical has a consensus price target of $10.00, indicating a potential upside of 139.52%. Given Outset Medical's stronger consensus rating and higher possible upside, analysts plainly believe Outset Medical is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

24.5% of PetVivo shares are held by institutional investors. 10.8% of PetVivo shares are held by insiders. Comparatively, 2.5% of Outset Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Outset Medical had 3 more articles in the media than PetVivo. MarketBeat recorded 6 mentions for Outset Medical and 3 mentions for PetVivo. Outset Medical's average media sentiment score of 0.54 beat PetVivo's score of 0.00 indicating that Outset Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Outset Medical	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Outset Medical has a net margin of -63.06% compared to PetVivo's net margin of -902.82%. Outset Medical's return on equity of -61.67% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Outset Medical	-63.06%	-61.67%	-28.25%

PetVivo has higher earnings, but lower revenue than Outset Medical. PetVivo is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	24.58	-$10.95M	-$0.34	N/A
Outset Medical	$117.80M	0.67	-$81.65M	-$4.09	N/A

PetVivo has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Outset Medical has a beta of 1.96, indicating that its stock price is 96% more volatile than the broader market.

Summary

Outset Medical beats PetVivo on 11 of the 16 factors compared between the two stocks.

How does PetVivo compare to NeurAxis?

PetVivo (NASDAQ:PETV) and NeurAxis (NASDAQ:NRXS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.

24.5% of PetVivo shares are owned by institutional investors. Comparatively, 11.8% of NeurAxis shares are owned by institutional investors. 10.8% of PetVivo shares are owned by insiders. Comparatively, 21.1% of NeurAxis shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

PetVivo has higher earnings, but lower revenue than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	24.58	-$10.95M	-$0.34	N/A
NeurAxis	$5.32M	14.80	-$14.63M	-$0.78	N/A

In the previous week, PetVivo had 1 more articles in the media than NeurAxis. MarketBeat recorded 3 mentions for PetVivo and 2 mentions for NeurAxis. NeurAxis' average media sentiment score of 0.20 beat PetVivo's score of 0.00 indicating that NeurAxis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NeurAxis	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PetVivo has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, NeurAxis has a beta of 1.49, indicating that its share price is 49% more volatile than the broader market.

NeurAxis has a net margin of -492.76% compared to PetVivo's net margin of -902.82%. NeurAxis' return on equity of 0.00% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
NeurAxis	-492.76%	N/A	-641.25%

NeurAxis has a consensus price target of $13.00, suggesting a potential upside of 107.50%. Given NeurAxis' stronger consensus rating and higher possible upside, analysts clearly believe NeurAxis is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
NeurAxis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

NeurAxis beats PetVivo on 9 of the 16 factors compared between the two stocks.

How does PetVivo compare to Pulmonx?

Pulmonx (NASDAQ:LUNG) and PetVivo (NASDAQ:PETV) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

91.0% of Pulmonx shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 7.5% of Pulmonx shares are owned by insiders. Comparatively, 10.8% of PetVivo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Pulmonx has a beta of 0.28, meaning that its share price is 72% less volatile than the broader market. Comparatively, PetVivo has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market.

In the previous week, Pulmonx and Pulmonx both had 3 articles in the media. Pulmonx's average media sentiment score of 1.11 beat PetVivo's score of 0.00 indicating that Pulmonx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pulmonx	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Pulmonx presently has a consensus target price of $7.67, indicating a potential upside of 237.89%. Given Pulmonx's stronger consensus rating and higher possible upside, equities analysts plainly believe Pulmonx is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulmonx	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

PetVivo has lower revenue, but higher earnings than Pulmonx. PetVivo is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulmonx	$87.44M	1.11	-$54M	-$1.16	N/A
PetVivo	$1.05M	24.58	-$10.95M	-$0.34	N/A

Pulmonx has a net margin of -55.03% compared to PetVivo's net margin of -902.82%. Pulmonx's return on equity of -96.66% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulmonx	-55.03%	-96.66%	-38.32%
PetVivo	-902.82%	-4,813.07%	-281.78%

Summary

Pulmonx beats PetVivo on 9 of the 15 factors compared between the two stocks.

How does PetVivo compare to Nano-X Imaging?

Nano-X Imaging (NASDAQ:NNOX) and PetVivo (NASDAQ:PETV) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

In the previous week, Nano-X Imaging had 3 more articles in the media than PetVivo. MarketBeat recorded 6 mentions for Nano-X Imaging and 3 mentions for PetVivo. Nano-X Imaging's average media sentiment score of 0.41 beat PetVivo's score of 0.00 indicating that Nano-X Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nano-X Imaging	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PetVivo has lower revenue, but higher earnings than Nano-X Imaging. PetVivo is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$14.52M	4.29	-$75.02M	-$1.58	N/A
PetVivo	$1.05M	24.58	-$10.95M	-$0.34	N/A

Nano-X Imaging has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market. Comparatively, PetVivo has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market.

Nano-X Imaging has a net margin of -716.44% compared to PetVivo's net margin of -902.82%. Nano-X Imaging's return on equity of -70.96% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-716.44%	-70.96%	-62.26%
PetVivo	-902.82%	-4,813.07%	-281.78%

Nano-X Imaging currently has a consensus price target of $4.33, indicating a potential upside of 387.99%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, equities research analysts clearly believe Nano-X Imaging is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by insiders. Comparatively, 10.8% of PetVivo shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Nano-X Imaging beats PetVivo on 11 of the 16 factors compared between the two stocks.

Get PetVivo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PETV vs. The Competition

Export

Metric	PetVivo	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$25.72M	$5.79B	$7.09B	$12.84B
Dividend Yield	N/A	1.75%	2.56%	10.63%
P/E Ratio	-1.51	26.12	270.36	24.72
Price / Sales	24.58	64.94	611.69	86.48
Price / Cash	N/A	33.83	28.87	38.47
Price / Book	-22.59	6.03	11.31	6.46
Net Income	-$10.95M	$149.25M	$3.45B	$347.47M
7 Day Performance	-6.23%	1.77%	1.13%	0.21%
1 Month Performance	-11.83%	5.64%	2.52%	1.52%
1 Year Performance	-17.82%	9.33%	62.43%	19.37%

PetVivo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PETV PetVivo	N/A	$0.68 -0.7%	N/A	-15.9%	$25.72M	$1.05M	N/A	20	High Trading Volume
HYPR Hyperfine	2.6196 of 5 stars	$0.96 -2.7%	$1.78 +86.7%	-35.6%	$97.48M	$11.40M	N/A	190
OM Outset Medical	2.8158 of 5 stars	$4.90 -5.8%	$10.00 +104.1%	-66.1%	$96.39M	$119.48M	N/A	520	Analyst Upgrade High Trading Volume
NRXS NeurAxis	1.7217 of 5 stars	$7.09 +2.3%	$13.00 +83.4%	+160.6%	$88.46M	$4.28M	N/A	19
LUNG Pulmonx	2.7474 of 5 stars	$2.04 -0.5%	$7.67 +275.8%	+42.9%	$88.04M	$90.50M	N/A	250	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PETV) was last updated on 8/18/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PetVivo (PETV) Competitors